A 21-gene test performed on tumours could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according to a landmark study.
Genomics will change what patients expect from their provider, as well as change how physicians treat them. Before this happens, education on both sides is needed. This month we look at some of the big talking points.
Whilst biotech companies are rushing to bring transformative gene therapies to market, states are too slow on adopting screening tests for genetic diseases that are, increasingly, treatable.
U.S. regulators have put a halt on a clinical trial planned to use CRISPR technology on sickle-cell patients due to ‘unspecified questions’, CRISPR Therapeutics said on Wednesday.
Japanese scientists now have permission to treat people who have heart disease with cells produced by a revolutionary reprogramming technique, which excites researchers. But some fear the therapy will be rushed to market.
Fetuses with a specific, rare chromosomal aberration have a 20% risk of developmental or other brain disorder, new research shows. The work could lead to personalised diagnostics and counselling for pregnant women.
Genetics is influencing more and more of our decisions, but we can’t make the right choices if we don’t understand it.
The NIH’s All of Us Research Program issued a funding announcement yesterday for Genome Centres to generate genotype and whole genome sequence data from participants’ biosamples.
A new study shows for the first time, that the levels of the same two sperm miRNAs change in both men and mice exposed to early life stress.
In this open discussion webinar, DNA Genotek and Illumina discuss what’s trending in whole genome sequencing (WGS).
A major new analysis reveals for the first time the likely cause of most cases of childhood leukaemia, and that the disease might be preventable.